Africa: Groundbreaking MSF Trial Finds Better Treatment for People With Drug-Resistant Tuberculosis

[MSF] A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis (MDR-TB) than the current options for people with drug-resistant TB (DR-TB), according to the results of an MSF study published in the New England Journal of Medicine today.

Related posts

Leave a Comment

%d bloggers like this: